Sylvia Cheung
Direttore Finanziario/CFO presso OCULIS HOLDING AG
Patrimonio netto: 798 356 $ in data 30/04/2024
Profilo
Sylvia Cheung is currently the Chief Financial Officer at Oculis Holding AG since 2020.
Prior to this, she worked as the Chief Financial Officer & Treasurer at Anika Therapeutics, Inc. from 2005 to 2020.
Before that, she was a Principal at Transkaryotic Therapies, Inc. from 2000 to 2005 and a Senior Audit Associate at PricewaterhouseCoopers LLP from 1995 to 2000.
She also served as the General Manager at Anika Therapeutics Srl.
Ms. Cheung holds an MBA from Boston University and an undergraduate degree from the University of Massachusetts.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OCULIS HOLDING AG
0.18% | 31/12/2023 | 66 808 ( 0.18% ) | 798 356 $ | 30/04/2024 |
Posizioni attive di Sylvia Cheung
| Società | Posizione | Inizio |
|---|---|---|
| OCULIS HOLDING AG | Direttore Finanziario/CFO | 01/09/2020 |
Precedenti posizioni note di Sylvia Cheung
| Società | Posizione | Fine |
|---|---|---|
| ANIKA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 10/08/2020 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01/01/2000 |
Formazione di Sylvia Cheung
| University of Massachusetts | Undergraduate Degree |
| Boston University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| OCULIS HOLDING AG | Health Technology |
| Aziende private | 2 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Borsa valori
- Insiders
- Sylvia Cheung
